Replimune Group, Inc. (REPL)
5.21
+0.05
(+0.97%)
USD |
NASDAQ |
May 21, 16:00
5.33
+0.12
(+2.30%)
After-Hours: 19:59
Replimune Group Accounts Payable (Quarterly) : 5.647M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.21M |
| Catalyst Pharmaceuticals, Inc. | 7.151M |
| Spyre Therapeutics, Inc. | 5.692M |
| Bristol Myers Squibb Co. | 4.234B |
| ANI Pharmaceuticals, Inc. | 69.69M |